These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32205069)

  • 1. Antibiofilm and mucolytic action of nitric oxide delivered via gas or macromolecular donor using in vitro and ex vivo models.
    Rouillard KR; Hill DB; Schoenfisch MH
    J Cyst Fibros; 2020 Nov; 19(6):1004-1010. PubMed ID: 32205069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
    Howlin RP; Cathie K; Hall-Stoodley L; Cornelius V; Duignan C; Allan RN; Fernandez BO; Barraud N; Bruce KD; Jefferies J; Kelso M; Kjelleberg S; Rice SA; Rogers GB; Pink S; Smith C; Sukhtankar PS; Salib R; Legg J; Carroll M; Daniels T; Feelisch M; Stoodley P; Clarke SC; Connett G; Faust SN; Webb JS
    Mol Ther; 2017 Sep; 25(9):2104-2116. PubMed ID: 28750737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung.
    Harrington NE; Sweeney E; Alav I; Allen F; Moat J; Harrison F
    J Vis Exp; 2021 Jan; (167):. PubMed ID: 33554970
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Rouillard KR; Markovetz MR; Bacudio LG; Hill DB; Schoenfisch MH
    ACS Infect Dis; 2020 Jul; 6(7):1940-1950. PubMed ID: 32510928
    [No Abstract]   [Full Text] [Related]  

  • 5. Improved clearability of cystic fibrosis sputum with dextran treatment in vitro.
    Feng W; Garrett H; Speert DP; King M
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):710-4. PubMed ID: 9517580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption and eradication of P. aeruginosa biofilms using nitric oxide-releasing chitosan oligosaccharides.
    Reighard KP; Hill DB; Dixon GA; Worley BV; Schoenfisch MH
    Biofouling; 2015; 31(9-10):775-87. PubMed ID: 26610146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis.
    Charrier C; Rodger C; Robertson J; Kowalczuk A; Shand N; Fraser-Pitt D; Mercer D; O'Neil D
    Orphanet J Rare Dis; 2014 Nov; 9():189. PubMed ID: 25433388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiofilm Efficacy of Nitric Oxide-Releasing Alginates against Cystic Fibrosis Bacterial Pathogens.
    Ahonen MJR; Dorrier JM; Schoenfisch MH
    ACS Infect Dis; 2019 Aug; 5(8):1327-1335. PubMed ID: 31136714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung.
    Kirchner S; Fothergill JL; Wright EA; James CE; Mowat E; Winstanley C
    J Vis Exp; 2012 Jun; (64):e3857. PubMed ID: 22711026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Improved Inhaled Mucolytic to Treat Airway Muco-obstructive Diseases.
    Ehre C; Rushton ZL; Wang B; Hothem LN; Morrison CB; Fontana NC; Markovetz MR; Delion MF; Kato T; Villalon D; Thelin WR; Esther CR; Hill DB; Grubb BR; Livraghi-Butrico A; Donaldson SH; Boucher RC
    Am J Respir Crit Care Med; 2019 Jan; 199(2):171-180. PubMed ID: 30212240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial Action of Nitric Oxide-Releasing Chitosan Oligosaccharides against Pseudomonas aeruginosa under Aerobic and Anaerobic Conditions.
    Reighard KP; Schoenfisch MH
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6506-13. PubMed ID: 26239983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections.
    Meers P; Neville M; Malinin V; Scotto AW; Sardaryan G; Kurumunda R; Mackinson C; James G; Fisher S; Perkins WR
    J Antimicrob Chemother; 2008 Apr; 61(4):859-68. PubMed ID: 18305202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mode of nitric oxide delivery affects antibacterial action.
    Hall JR; Rouillard KR; Suchyta DJ; Brown MD; Ahonen MJR; Schoenfisc MH
    ACS Biomater Sci Eng; 2020 Jan; 6(1):433-441. PubMed ID: 32671191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide-releasing chitosan oligosaccharides as antibacterial agents.
    Lu Y; Slomberg DL; Schoenfisch MH
    Biomaterials; 2014 Feb; 35(5):1716-24. PubMed ID: 24268196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro.
    Bahamondez-Canas TF; Zhang H; Tewes F; Leal J; Smyth HDC
    Mol Pharm; 2018 Apr; 15(4):1643-1652. PubMed ID: 29514003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-Linked Lipid Nanocarriers for Coping Pseudomonal Pulmonary Infection. Would Nanocarriers Complement Biofilm Disruption or Pave Its Road?
    Nafee N; Gaber DM; Abouelfetouh A; Alseqely M; Empting M; Schneider M
    Int J Nanomedicine; 2024; 19():3861-3890. PubMed ID: 38708178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Nitric Oxide-Releasing Chitosan Oligosaccharides on Mucus Viscoelasticity.
    Reighard KP; Ehre C; Rushton ZL; Ahonen MJR; Hill DB; Schoenfisch MH
    ACS Biomater Sci Eng; 2017; 3(6):1017-1026. PubMed ID: 30320206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of photosensitisers and light through mucus: investigations into the potential use of photodynamic therapy for treatment of Pseudomonas aeruginosa cystic fibrosis pulmonary infection.
    Donnelly RF; McCarron PA; Cassidy CM; Elborn JS; Tunney MM
    J Control Release; 2007 Feb; 117(2):217-26. PubMed ID: 17196290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and Genotypic Adaptations in Pseudomonas aeruginosa Biofilms following Long-Term Exposure to an Alginate Oligomer Therapy.
    Oakley JL; Weiser R; Powell LC; Forton J; Mahenthiralingam E; Rye PD; Hill KE; Thomas DW; Pritchard MF
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.